Literature DB >> 6113192

Comparison of twice-daily ranitidine with standard cimetidine treatment of duodenal ulcer.

R P Walt, I F Trotman, R Frost, P L Golding, T H Shepherd, J Rawlings, R H Hunt, D Colin-Jones, G J Milton-Thompson, J J Misiewicz.   

Abstract

One hundred and three outpatients with endoscopically diagnosed duodenal ulcer were randomly allocated to treatment with either cimetidine 200 mg tds and 400 mg nocte, or ranitidine 150 mg bd for four weeks. The endoscopists were not aware of the treatment and took no part in the clinical management. On completion of treatment ulcers had healed in 43 of 51 (84%) patients given cimetidine and in 40 of 52 (77%) patients given ranitidine. There were no serious unwanted effects in either treatment group. The results show no significant difference between healing rates after four weeks of standard cimetidine therapy or ranitidine 150 mg bd.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6113192      PMCID: PMC1419156          DOI: 10.1136/gut.22.4.319

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  9 in total

1.  Cimetidine in the treatment of duodenal ulcer: a multicenter double blind study.

Authors:  H J Binder; A Cocco; R J Crossley; W Finkelstein; R Font; G Friedman; J Groarke; W Hughes; A F Johnson; J E McGuigan; R Summers; R Vlahcevic; E C Wilson; D H Winship
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

2.  Comparison of ranitidine and cimetidine in the inhibition of histamine, sham-feeding, and meal-induced gastric secretion in duodenal ulcer patients.

Authors:  S J Konturek; W Obtulowicz; N Kwiecien; E Sito; E Mikos; J Oleksy
Journal:  Gut       Date:  1980-03       Impact factor: 23.059

3.  Inhibition of gastric secretion in man with a new H2-receptor antagonist, ranitidine.

Authors:  K Kett; E Aadland; A Berstad
Journal:  Scand J Gastroenterol       Date:  1980       Impact factor: 2.423

4.  Histamine H2-receptor antagonists in the treatment of duodenal ulcers.

Authors:  S Bank; G O Barbezat; B H Novis; L O Tim; H S Odes; C Helman; L Narunsky; P J Duys; I N Marks
Journal:  S Afr Med J       Date:  1976-10-16

5.  Cimetidine treatment of duodenal ulceration: short term clinical trial and maintenance study.

Authors:  D J Hetzel; P J Hansky; D J Shearman; M G Korman; R Hecker; G J Taggart; R Jackson; B W Gabb
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

6.  Inhibition of pentagastrin-stimulated and nocturnal gastric secretion by ranitidine. A new H2-receptor antagonist.

Authors:  N R Peden; J H Saunders; K G Wormsley
Journal:  Lancet       Date:  1979-03-31       Impact factor: 79.321

7.  Inhibition of gastric acid secretion in the dog by the H2-receptor antagonists, ranitidine, cimetidine, and metiamide.

Authors:  M J Daly; J M Humphray; R Stables
Journal:  Gut       Date:  1980-05       Impact factor: 23.059

8.  Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.

Authors:  R P Walt; P J Male; J Rawlings; R H Hunt; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1981-01       Impact factor: 23.059

9.  Treatment of duodenal ulcer with ranitidine, a new histamine H2-receptor antagonist.

Authors:  A Berstad; K Kett; E Aadland; E Carlsen; K Frislid; K Saxhaug; A Kruse-Jensen
Journal:  Scand J Gastroenterol       Date:  1980       Impact factor: 2.423

  9 in total
  13 in total

Review 1.  Gastroenterology in the armed forces.

Authors:  G Milton-Thompson
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

Review 2.  Newer antisecretory agents for peptic ulcer.

Authors:  K W Somerville; M J Langman
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

3.  Effect of no treatment, cimetidine 1 g/day, cimetidine 2 g/day and cimetidine combined with atropine on nocturnal gastric secretion in cimetidine non-responders.

Authors:  T Gledhill; M Buck; R H Hunt
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

4.  Daytime acid secretion after a single dose of ranitidine and cimetidine--a double blind crossover study.

Authors:  V F Eckardt; I Cordes; H D Janisch; H Wiemann
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.

Authors:  T Gledhill; O M Howard; M Buck; A Paul; R H Hunt
Journal:  Gut       Date:  1983-10       Impact factor: 23.059

6.  The controlled trial.

Authors:  R Doll
Journal:  Postgrad Med J       Date:  1984-11       Impact factor: 2.401

7.  Neurological and psychiatric side effects of cimetidine--report of 3 cases with review of the literature.

Authors:  M Sonnenblick; A J Rosin; N Weissberg
Journal:  Postgrad Med J       Date:  1982-07       Impact factor: 2.401

Review 8.  Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

9.  [Histological and ultrastructural findings in the healing phase of duodenal ulcer].

Authors:  P Malfertheiner; G Bode; U Mader; K Baczako; A Stanescu; H Ditschuneit
Journal:  Klin Wochenschr       Date:  1985-10-15

10.  Treatment of 'cimetidine-resistant' chronic duodenal ulcers with ranitidine or cimetidine: a randomised multicentre study.

Authors:  M Quatrini; G Basilisco; P A Bianchi
Journal:  Gut       Date:  1984-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.